Technology | 2022.10.25
FUJIFILM Diosynth Biotechnologies and RoosterBio Announce Collaboration to Enable GMP Manufacturing of Cell and Exosome Therapies
Through this collaboration, FUJIFILM Diosynth Biotechnologies will incorporate RoosterBio's industry-leading process development technology for both MSC and extracellular vesicle (EV) / exosome programs into its manufacturing capabilities and offerings.
(PRWeb October 25, 2022)
Read the full story at https://www.prweb.com/releases/fujifilm_diosynth_biotechnologies_and_roosterbio_announce_collaboration_to_enable_gmp_manufacturing_of_cell_and_exosome_therapies/prweb18978070.htm
For more information, please visit
https://www.prweb.com/releases/fujifilm_[...]me_therapies/prweb18978070.htm
